vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $186.9M, roughly 1.0× Limbach Holdings, Inc.). Limbach Holdings, Inc. runs the higher net margin — 6.6% vs -14.6%, a 21.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 30.1%). Limbach Holdings, Inc. produced more free cash flow last quarter ($27.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 25.3%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
AXSM vs LMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $186.9M |
| Net Profit | $-28.6M | $12.3M |
| Gross Margin | — | 25.7% |
| Operating Margin | -13.8% | 9.4% |
| Net Margin | -14.6% | 6.6% |
| Revenue YoY | 65.0% | 30.1% |
| Net Profit YoY | 61.9% | 25.0% |
| EPS (diluted) | $-0.55 | $1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $186.9M | ||
| Q3 25 | $171.0M | $184.6M | ||
| Q2 25 | $150.0M | $142.2M | ||
| Q1 25 | $121.5M | $133.1M | ||
| Q4 24 | $118.8M | $143.7M | ||
| Q3 24 | $104.8M | $133.9M | ||
| Q2 24 | $87.2M | $122.2M | ||
| Q1 24 | $75.0M | $119.0M |
| Q4 25 | $-28.6M | $12.3M | ||
| Q3 25 | $-47.2M | $8.8M | ||
| Q2 25 | $-48.0M | $7.8M | ||
| Q1 25 | $-59.4M | $10.2M | ||
| Q4 24 | $-74.9M | $9.8M | ||
| Q3 24 | $-64.6M | $7.5M | ||
| Q2 24 | $-79.3M | $6.0M | ||
| Q1 24 | $-68.4M | $7.6M |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 28.0% | ||
| Q1 25 | — | 27.6% | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | — | 27.0% | ||
| Q2 24 | — | 27.4% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | -13.8% | 9.4% | ||
| Q3 25 | -27.0% | 7.2% | ||
| Q2 25 | -24.5% | 7.5% | ||
| Q1 25 | -46.9% | 5.9% | ||
| Q4 24 | -61.1% | 9.1% | ||
| Q3 24 | -59.8% | 8.1% | ||
| Q2 24 | -89.5% | 6.7% | ||
| Q1 24 | -89.7% | 5.5% |
| Q4 25 | -14.6% | 6.6% | ||
| Q3 25 | -27.6% | 4.8% | ||
| Q2 25 | -32.0% | 5.5% | ||
| Q1 25 | -48.9% | 7.7% | ||
| Q4 24 | -63.1% | 6.9% | ||
| Q3 24 | -61.7% | 5.6% | ||
| Q2 24 | -91.0% | 4.9% | ||
| Q1 24 | -91.1% | 6.4% |
| Q4 25 | $-0.55 | $1.01 | ||
| Q3 25 | $-0.94 | $0.73 | ||
| Q2 25 | $-0.97 | $0.64 | ||
| Q1 25 | $-1.22 | $0.85 | ||
| Q4 24 | $-1.54 | $0.81 | ||
| Q3 24 | $-1.34 | $0.62 | ||
| Q2 24 | $-1.67 | $0.50 | ||
| Q1 24 | $-1.44 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $11.3M |
| Total DebtLower is stronger | — | $30.5M |
| Stockholders' EquityBook value | $88.3M | $195.7M |
| Total Assets | $689.8M | $381.1M |
| Debt / EquityLower = less leverage | — | 0.16× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $11.3M | ||
| Q3 25 | $325.3M | $9.8M | ||
| Q2 25 | $303.0M | $38.9M | ||
| Q1 25 | $300.9M | $38.1M | ||
| Q4 24 | $315.4M | $44.9M | ||
| Q3 24 | $327.3M | $51.2M | ||
| Q2 24 | $315.7M | $59.5M | ||
| Q1 24 | $331.4M | $48.2M |
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | $88.3M | $195.7M | ||
| Q3 25 | $73.7M | $181.6M | ||
| Q2 25 | $73.1M | $170.5M | ||
| Q1 25 | $53.2M | $161.1M | ||
| Q4 24 | $57.0M | $153.5M | ||
| Q3 24 | $92.9M | $142.2M | ||
| Q2 24 | $102.9M | $133.0M | ||
| Q1 24 | $144.0M | $125.5M |
| Q4 25 | $689.8M | $381.1M | ||
| Q3 25 | $669.3M | $409.1M | ||
| Q2 25 | $639.8M | $343.0M | ||
| Q1 25 | $596.7M | $336.4M | ||
| Q4 24 | $568.5M | $352.1M | ||
| Q3 24 | $561.5M | $324.4M | ||
| Q2 24 | $548.2M | $303.9M | ||
| Q1 24 | $545.7M | $289.2M |
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $28.1M |
| Free Cash FlowOCF − Capex | $-18.7M | $27.9M |
| FCF MarginFCF / Revenue | -9.6% | 14.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 2.29× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $28.1M | ||
| Q3 25 | $1.0M | $13.3M | ||
| Q2 25 | $-32.4M | $2.0M | ||
| Q1 25 | $-43.4M | $2.2M | ||
| Q4 24 | $-26.2M | $19.3M | ||
| Q3 24 | $-18.6M | $4.9M | ||
| Q2 24 | $-30.1M | $16.5M | ||
| Q1 24 | $-53.5M | $-3.9M |
| Q4 25 | $-18.7M | $27.9M | ||
| Q3 25 | $988.0K | $12.8M | ||
| Q2 25 | $-32.4M | $1.2M | ||
| Q1 25 | $-43.7M | $11.0K | ||
| Q4 24 | $-26.2M | $18.0M | ||
| Q3 24 | $-18.7M | $4.6M | ||
| Q2 24 | $-30.2M | $13.2M | ||
| Q1 24 | $-53.6M | $-6.5M |
| Q4 25 | -9.6% | 14.9% | ||
| Q3 25 | 0.6% | 7.0% | ||
| Q2 25 | -21.6% | 0.8% | ||
| Q1 25 | -36.0% | 0.0% | ||
| Q4 24 | -22.1% | 12.5% | ||
| Q3 24 | -17.9% | 3.4% | ||
| Q2 24 | -34.6% | 10.8% | ||
| Q1 24 | -71.4% | -5.5% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.3% | 1.7% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.1% | 2.7% | ||
| Q1 24 | 0.1% | 2.1% |
| Q4 25 | — | 2.29× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 2.77× | ||
| Q1 24 | — | -0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
LMB
| Owner Direct Relationships Segment | $145.0M | 78% |
| General Contractor Construction Manager Relationships Segment | $41.9M | 22% |
